BDBM716487 N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cyanopyrrolidin-3-yl)-5-(5-cyano-2-cyclopropylphenyl)-N-cyclopropyloxazole-2-carboxamide::US20250034122, Example 2

SMILES N#Cc1ccc(C2CC2)c(-c2nnc(C(=O)N(C3CC3)[C@@H]3C[C@@H](Cn4ccnn4)N(C#N)C3)o2)c1

InChI Key InChIKey=DBTKWEYVGLBADT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 716487   

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mission Therapeutics

US Patent
LigandPNGBDBM716487(N-((3R,5S)-5-((1H-1,2,3-Triazol-1-yl)methyl)-1-cya...)
Affinity DataIC50: 11nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well polypropylen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent